CTN-0105: Integrating Pharmacy-Based Prevention and Treatment of Opioid and Other Substance Use Disorders: A Survey of Pharmacists and Stakeholders
Li-Tzy Wu, ScD, RN, MA
Lead Investigator
Department of Psychiatry and Behavioral Sciences
Duke University Medical Center
litzy.wu@duke.edu
This study will use mixed methods to study pharmacists’ knowledge of, attitudes about, and intention to provide patient care and services for Screening for substance use, Brief Intervention, and Referral to Treatment (SBIRT) for substance use disorders (SUDs) and Medication treatment for Opioid Use Disorders (MOUD). The findings will inform barriers and facilitators related to pharmacist-provided services and patient care for SBIRT and MOUD. A survey instrument for assessing such barriers and facilitators will be developed.
Funded by the NIH HEAL InitiativeSM.
Primary Findings
Overall, 75% of surveyed pharmacists indicated having concerns about opioid use problems, and 62% had concerns about non-opioid drug use problems at their pharmacies. Having received opioid-related training on screening, intervention, and referral to treatment in the past year was positively associated with their practice of delivering these services. Pharmacists who had actual experience delivering such services was also positively related to their commitment/readiness for providing services to individuals with opioid/drug use problems in the future.
Pharmacy staff’s capability of and involvement with delivering SBIRT services is considered a cornerstone of future pharmacy practice. State pharmacy boards and pharmacist associations could consider establishing an OUD certification or addiction training program to empower pharmacy staff’s involvement with delivering SBIRT services.
Primary Outcomes Article: Wu L, et al. Pharmacy-Based Preventive Services for Opioid Use Disorder: A Survey of U.S. Pharmacists. Addiction Science & Clinical Practice 2024;19:88. [get article]
Related Resources
Node Involvement
Lead Node(s):
All Participating Nodes: